Comparison between face masks and mouthpieces: effects on measurement of cough strength and use of a cough assist machine
- Conditions
- Neuromuscular diseaseNeurological - Other neurological disordersRespiratory muscle weaknessRespiratory - Other respiratory disorders / diseasesNeurological - Neurodegenerative diseases
- Registration Number
- ACTRN12624000199516
- Lead Sponsor
- Sydney Local Health District
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 43
Stage 1 and Stage 2 of the study:
-Medically stable individuals with suspected or known respiratory muscle weakness who are
greater than or equal to 18 years of age
- Able to provide informed consent and willing to participate and comply with the study requirements
Additional criteria for Stage 2 of the study:
- Free from contraindications to forced manoeuvres or positive pressure ventilation
Stage 1
- Inability to follow instructions
- Inability to understand written or verbal English
- Inability to obtain a seal lip with a mouthpiece
- Pain or other conditions that may impede cough
- Tracheostomy
- Standard contraindications to forced respiratory manoeuvres
Stage 2
- Standard contraindications to positive pressure therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Stage 1: Unassisted peak cough flow (L/min) with the oronasal mask compared to the mouthpiece interface<br>[Stage 1: Mini Wright peak flow meter attached to each interface<br> Stage 1: All measures will be completed during a single visit . Unassisted peak cough flow will be recorded on the data collection form immediately after each manoeuvre is performed. <br>];Stage 2: Peak cough flow (L/min) during mechanical in-exsufflation with the oronasal mask compared to the mouthpiece interface[Stage 2: The mechanical in-exsufflation machine will measure and display peak cough flow real-time for each interface<br> Stage 2: All measures will be completed in a single visit (this may be the same visit as Stage 1). Peak cough flow measured using the mechanical in-exsufflation device will be recorded on the data collection form immediately after each manoeuvre is performed.<br> <br>]
- Secondary Outcome Measures
Name Time Method